Consonance Capital Management LP Soleno Therapeutics Inc Transaction History
Consonance Capital Management LP
- $7.28 Million
- Q3 2022
Shares
2 transactions
Others Institutions Holding SLNO
# of Institutions
1Shares Held
550KCall Options Held
0Put Options Held
0About SOLENO THERAPEUTICS INC
- Ticker SLNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,101,250
- Market Cap $442M
- Description
- Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...